Why is the Virtus Health (ASX:VRT) share price frozen today?

Another ASX share is on ice this week pending an announcement.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Virtus Health shares are in a trading halt from this morning, requested by the company before the market open
  • Before being placed on ice, Virtus shares finished the day flat at $7.70 on Thursday 
  • In the past 12 months, the Virtus Health share price has climbed more than 26%

The Virtus Health Ltd (ASX: VRT) share price is currently halted after the company requested a trading pause before the market open today.

Virtus Health shares have posted solid gains so far in 2022, having shot up more than 26% over the previous 12 months of trading.

The $658 million company by market cap is also trading at its highest levels in more than five years and has thrust past its 52-week closing high during the past week or so (see below).

TradingView Chart
Female doctor with a mask holds out hand in a stop gesture.

Image source: Getty Images

A quick refresher

Presumably, Virtus requested the pause in lieu of a market-sensitive announcement. It suggested this is related to the takeover saga it is currently embroiled in.

For reference, Virtus is the subject of competing takeover offers made by BGH and CapVest Partners LLP. The Virtus Health share price jumped on the news of the CapVest offer on January 20.

Just yesterday the Australian Government Takeovers Panel (AGTP) made declarations on previous orders it had made with respect to CapVest's takeover proposal of the company.

It found "certain aspects of the exclusivity arrangements in a process deed between Virtus and CapVest had an anti-competitive effect", and made orders to amend the deed.

After review, Virtus opted to still side with CapVest's offer, something that BGH apparently became frustrated with.

"BGH submitted that, notwithstanding the clear intent of the Orders, the circumstances were continuing to unacceptably frustrate a proper auction process or competitive bidding environment," the AGTP said.

"It submitted that this was evidenced by Virtus disclosing the Revised BGH Proposal to CapVest, CapVest matching or improving its existing proposal and the Virtus board then dismissing the Revised BGH Proposal in preference to continuing to deal exclusively with CapVest."

However, the AGTP declined to comment on the matter and found no reason to conduct proceedings after its final review.

Why is Virtus on ice?

The company was granted the halt following a request made to the ASX today. Before being placed on ice, Virtus Health shares finished the day flat on Thursday at $7.70 apiece.

It says the trading halt is "necessary as the company expects to make an announcement to the market in relation to ongoing matters pertaining to proposals to acquire Virtus Health".

"Virtus requests the trading halt to last until the earlier of the time it makes the intended announcement to the ASX concerning the material potential transaction, or until the commencement of trading on Tuesday 15 March 2022."

Prior to the halt, Virtus finished the month well, after its share price made several steps up the ladder to set new single-year highs.

Virtus Health share price snapshot

In the past 12 months, the Virtus Health share price has climbed more than 26% and is up 12% this year to date. Over the past month, shares have walked another 5% into the green.

In fact, the company's share price is up across all major time frames and is thus leading the broader market this year to date.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Virtus Health Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX biotech has just announced a major US deal

This company's heart disease technology is gaining traction.

Read more »

Devastated woman sits near smartphone on home kitchen floor troubled with loneliness.
Healthcare Shares

Which beaten down ASX healthcare stock is a better buy right now: Pro Medicus vs Cochlear shares

Which do experts prefer?

Read more »

Health professional working on his laptop.
Healthcare Shares

Already up 42% this year, Morgans says this ASX healthcare stock can continue to rocket

This broker sees big upside for this healthcare stock.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX small-cap healthcare stock could rocket more than 50%: Morgans

Share price weakness could present an opportunity.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Guess which ASX 300 stock was given a big boost from the US FDA

This healthcare stock has made a positive announcement today.

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Healthcare Shares

Down 50%, why I'd invest $20,000 into CSL shares

A 50% decline in a blue-chip share can signal trouble, but not always a broken story.

Read more »